Archives
-
Deferasirox, Ferritinophagy, and Lysosomal Stress
2026-08-12
Deferasirox is an oral iron chelator whose experimental value extends beyond iron depletion. This article connects iron availability, glucose-starvation biology, ferritinophagy, and lysosomal cell death to help researchers design more discriminating assays.
-
Firefly Luciferase mRNA Workflow Guide
2026-08-12
Build stronger reporter assays with a Cap1-capped, 5-moUTP modified mRNA engineered for stable, sustained Fluc expression. This practical guide connects transcript handling, carrier selection, quantitative imaging, and troubleshooting for mRNA delivery, translation studies, and in vivo reporter work.
-
BV6: Selective IAP Antagonist Research Guide
2026-08-11
BV6 is a Smac-mimetic IAP antagonist for research on apoptosis induction in cancer cells, radiosensitization, chemotherapy response, and endometriosis models. Product data report a BV6 IC50 of 7.2 μM in H460 non-small cell lung cancer cells, while evidence remains model-specific and preclinical.
-
Firefly Luciferase mRNA for Delivery Assay Design
2026-08-11
Discover how Firefly Luciferase mRNA can function as more than a reporter: it can reveal the balance between cytosolic delivery, translation, transcript stability, and innate sensing. This guide applies insights from a calcium phosphate Pickering-emulsion study to practical 5-moUTP modified mRNA assay design.
-
EPZ5676: A Practical DOT1L Inhibitor Workflow
2026-08-10
EPZ5676 combines subnanomolar DOT1L potency with exceptional methyltransferase selectivity for mechanistic leukemia research. This guide translates that profile into reproducible biochemical, cellular, chromatin, and troubleshooting workflows centered on MLL-rearranged models.
-
Asunaprevir (BMS-650032): HCV NS3 Inhibitor
2026-08-09
Asunaprevir, also called BMS-650032, is an orally efficacious HCV NS3/4A protease inhibitor with nanomolar biochemical potency. Its research value lies in genotype-spanning HCV RNA replication inhibition, defined solubility behavior, and a mechanism distinct from host-cell chromatin or caspase signaling pathways.
-
Viral RIPK3 Degradation and Inflammation
2026-08-08
Liu and colleagues identified a viral inducer of RIPK3 degradation, or vIRD, that links orthopoxvirus immune evasion to SCF-mediated ubiquitination and proteasomal turnover. The study shows that vIRD-dependent suppression of necroptosis can increase viral replication and inflammatory disease, providing a mechanistic framework for studying host–pathogen regulation of protein degradation.
-
Cytarabine Assays: DNA Stress and Necroptosis
2026-08-07
Cytarabine is more than a leukemia chemotherapy agent: it is a controllable model of nucleotide-driven replication stress. This guide shows how to distinguish AraC-induced DNA damage and apoptosis from RIPK3-dependent necroptosis, using practical assay logic grounded in primary research.
-
Virus-Mimicking Particles Enable Extrahepatic mRNA Delivery
2026-08-07
The reference study introduces a bottom-up engineered enveloped virus-mimicking particle (EVMP) that achieves efficient, organ-targeted mRNA delivery beyond the liver—a major leap for mRNA therapeutics. The approach overcomes traditional hepatic tropism and immunogenicity, offering new routes for in vivo gene expression and disease treatment outside hepatic tissues.
-
Oseltamivir Acid: Mechanistic Leverage for Translational Inn
2026-08-06
This thought-leadership article dissects the mechanistic and strategic dimensions of Oseltamivir acid as both a benchmark influenza neuraminidase inhibitor and an emerging tool in cancer metastasis research. By synthesizing evidence from prodrug metabolism studies and integrating cross-domain insights, we chart a forward-thinking strategy for translational researchers navigating antiviral and oncology frontiers.
-
Angiotensin 1/2 (1-6): Mechanistic Basis and RAS Research Ut
2026-08-06
Angiotensin 1/2 (1-6), an Asp-Arg-Val-Tyr-Ile-His hexapeptide, is a potent tool for dissecting renin-angiotensin system dynamics and vascular tone modulation. Its precise mechanistic role and robust physicochemical profile make it central to cardiovascular and renal function studies.
-
Netrin-1 Modulates Adipogenesis via PPARγ and Wnt/β-catenin
2026-08-05
This study elucidates the role of adipose-derived Netrin-1 in regulating adipogenesis under high-fat diet conditions, revealing that Netrin-1 impairs compensatory adipose tissue remodeling by modulating PPARγ and Wnt/β-catenin signaling. The findings have significant implications for understanding obesity pathophysiology and identify Netrin-1 as a potential therapeutic target for metabolic disorders.
-
CD28-ARS2-PKM Axis Drives CD8+ T Cell Metabolic Flexibility
2026-08-05
This study uncovers how the CD28-ARS2 axis orchestrates alternative splicing of the pyruvate kinase M (PKM) gene, promoting the PKM2 isoform in CD8+ T cells and supporting their antitumor function. The findings detail a posttranscriptional mechanism for metabolic reprogramming in T cell immunity, with implications for immunometabolic modulation in oncology research.
-
TMEM16F in Kupffer Cells Restricts Listeria-Induced Liver In
2026-08-04
This study uncovers that TMEM16F, a calcium-activated lipid scramblase, plays a crucial cell-type-specific role in liver Kupffer cells, protecting against Listeria monocytogenes-induced tissue damage by maintaining plasma membrane integrity and regulating inflammatory responses. The findings clarify the mechanisms of host defense and suggest targeted approaches for studying inflammatory liver injury.
-
Applied Workflows with Angiotensin (1-7): Protocols & Pitfal
2026-08-04
Leverage Angiotensin (1-7), the Mas receptor agonist, for robust anti-fibrotic, metabolic, and neuroprotective research. This guide delivers actionable protocols, troubleshooting insights, and data-driven comparisons to maximize the translational impact of this endogenous heptapeptide hormone.